Page last updated: 2024-10-15

2-keto-4-methylvalerate and Metabolic Diseases

2-keto-4-methylvalerate has been researched along with Metabolic Diseases in 1 studies

alpha-ketoisocaproic acid: RN given refers to parent cpd
4-methyl-2-oxopentanoate : A 2-oxo monocarboxylic acid anion that is the conjugate base of 4-methyl-2-oxopentanoic acid.
4-methyl-2-oxopentanoic acid : A 2-oxo monocarboxylic acid that is pentanoic acid (valeric acid) substituted with a keto group at C-2 and a methyl group at C-4. A metabolite that has been found to accumulate in maple syrup urine disease.

Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rountree, AM1
Neal, AS1
Lisowski, M1
Rizzo, N1
Radtke, J1
White, S1
Luciani, DS1
Kim, F1
Hampe, CS1
Sweet, IR1

Other Studies

1 other study available for 2-keto-4-methylvalerate and Metabolic Diseases

ArticleYear
Control of insulin secretion by cytochrome C and calcium signaling in islets with impaired metabolism.
    The Journal of biological chemistry, 2014, Jul-04, Volume: 289, Issue:27

    Topics: Animals; Calcium Signaling; Cytochromes c; Dose-Response Relationship, Drug; Energy Metabolism; Fast

2014